hock peng koh, adyani md redzuan, shamin mohd saffian, hasnita hassan, jivanraj r. nagarajah, noel thomas ross.  (2023).  mortality outcomes and predictors of failed thrombolysis following stemi thrombolysis in a non-pci capable tertiary hospital: a 5-year analysis.  - internal and emergency medicine.  1169-1180. 

farhana fakhira ismail, adyani md redzuan, wei wen chong, mariani ahmad nizaruddin.  (2023).  role of community pharmacists in cardiovascular diseases-related health promotion and dyslipidemia management in malaysia: a nationwide cross-sectional study.  - plos one.  1-15. 

fei yee lee, farida islahudin, abdul halim abdul gafor, hin-seng wong, sunita bavanandan, shamin mohd saffian, adyani md redzuan, mohd makmor-bakry.  (2022).  adverse drug reactions of antihypertensives and cyp3a5*3 polymorphism among chronic kidney disease patients.  - frontiers in pharmacology.  1-8. 

hock peng koh, adyani md redzuan, shamin mohd saffian, jivanraj r. nagarajah, noel thomas ross, hasnita hassan.  (2022).  clinical profile and predictors of 30-day all-cause mortality of stelevation myocardial infarction (stemi) patients receiving fibrinolytic therapy in an asian population.  - heart & lung.  68-76. 

hock peng koh, adyani md redzuan, shamin mohd saffian, jivanraj nagarajah, noel thomas ross, hasnita hassan.  (2022).  impact of covid-19 pandemic on stemi thrombolysis and emergency department's performance in a non-pci capable tertiary hospital.  - american journal of emergency medicine.  9-14. 

fei yee lee, farida islahudin, aina yazrin ali nasiruddin, abdul halim abdul gafor, hin-seng wong, sunita bavanandan, shamin mohd saffian, adyani md redzuan, nurul ain mohd tahir, mohd makmor-bakry.  (2021).  effects of cyp3a5 polymorphism on rapid progression of chronic kidney disease: a prospective, multicentre study.  - journal of personalized medicine.  1-14. 

salmi abdul razak, mohd makmor bakry, mohd shahrir mohamed said, chai-eng tan, adyani md redzuan.  (2020).  development and validation of adherence score for subcutaneous biologic disease-modifying antirheumatic drugs.  - frontiers in pharmacology.  1-9. 

s. b. choo, a. saifulbahri, s. n. zullkifli, m. l. fadzil, a. md. redzuan, n. abdullah, r. s. ahmad bustamam, h. z. ahmad & n. mohamed shah.  (2019).  adjuvant endocrine therapy side-effects among postmenopausal breast cancer patients in malaysia.  - climacteric.  . 

siti-zainora mohd-zulkefli, marhanis-salihah omar, adyani md-redzuan.  (2016).  factors associated with lipid goal attainment among acute coronary syndrome patients.  - patient preference and adherence.  1631-1637. 

adyani md redzuan, meng lee soon, noraida mohamed shah.  (2014).  adherence to preventive medications in asthmatic children at a tertiary care teaching hospital in malaysia.  - patient preference and adherence.  8:263-270.